Immediate Impact
1 from Science/Nature 20 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
The issue of heterogeneity of MSC-based advanced therapy medicinal products–a review
2024 Standout
Works of Simon Krabbe being referenced
Using a DAS28-CRP-steered treat-to-target strategy does not eliminate subclinical inflammation as assessed by ultrasonography in rheumatoid arthritis patients in longstanding clinical remission
2021
Risk of serious infections in arthritis patients treated with biological drugs: a matched cohort study and development of prediction model
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Simon Krabbe | 378 | 145 | 135 | 150 | 46 | 457 | |
| F. Maas | 410 | 123 | 181 | 93 | 26 | 461 | |
| Gianantonio Saviola | 261 | 65 | 95 | 45 | 41 | 448 | |
| L. Zakraoui | 229 | 30 | 88 | 79 | 57 | 409 | |
| Marine Forien | 232 | 32 | 103 | 61 | 42 | 445 | |
| Xuerong Deng | 307 | 17 | 116 | 85 | 41 | 477 | |
| Jean‐Hugues Salmon | 248 | 42 | 68 | 51 | 42 | 471 | |
| F. Wink | 413 | 113 | 216 | 95 | 42 | 491 | |
| Judith Rademacher | 327 | 59 | 170 | 66 | 47 | 485 | |
| W.F. Lems | 335 | 91 | 39 | 69 | 38 | 470 | |
| Kirsten Karberg | 337 | 88 | 92 | 88 | 38 | 406 |
All Works
Login with ORCID to disown or claim papers
Loading papers...